Immunovant
Alicia Bloom is an experienced supply chain professional with a strong background in managing commercial supply chains across multiple pharmaceutical companies. Currently serving as Associate Director at Immunovant since December 2022, Alicia has previously held senior roles at Agios Pharmaceuticals and Tetraphase Pharmaceuticals, where responsibilities included planning, coordinating logistics, and ensuring the timely delivery of commercial products. Alicia's experience spans from supply chain management and procurement to logistics support for clinical studies. Alicia holds a Bachelor of Science in Business Administration and Management with a focus on Supply Chain Management from Northeastern University and is pursuing an MBA at Boston College.
This person is not in any teams
This person is not in any offices
Immunovant
6 followers
Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Immunovant is developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated by pathogenic IgG antibodies.